128 related articles for article (PubMed ID: 6429814)
1. Inactivated poliovirus vaccine: current production methods and new developments.
van Wezel AL; van Steenis G; van der Marel P; Osterhaus AD
Rev Infect Dis; 1984; 6 Suppl 2():S335-40. PubMed ID: 6429814
[TBL] [Abstract][Full Text] [Related]
2. Feasible improvements in vaccines in the Expanded Programme on Immunization.
McIntosh K
Rev Infect Dis; 1989; 11 Suppl 3():S530-7. PubMed ID: 2669097
[TBL] [Abstract][Full Text] [Related]
3. Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents.
Bégué PC; Grimprel EM; Giovannangeli MD; Abitbol VI
Pediatr Infect Dis J; 1998 Sep; 17(9):804-9. PubMed ID: 9779766
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new combined inactivated DPT-polio vaccine.
Drucker J; Soula G; Diallo O; Fabre P
Dev Biol Stand; 1986; 65():145-51. PubMed ID: 3030861
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood.
Eskola J; Käyhty H; Gordon LK; Hovi T; Stenvik M; Rönnberg PR; Kela E; Peltola H
Pediatr Infect Dis J; 1988 Jul; 7(7):480-4. PubMed ID: 3261414
[TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants.
Halperin SA; Davies HD; Barreto L; Guasparini R; Meekison W; Humphreys G; Eastwood BJ
J Pediatr; 1997 Apr; 130(4):525-31. PubMed ID: 9108847
[TBL] [Abstract][Full Text] [Related]
8. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults.
Kovac M; Rathi N; Kuriyakose S; Hardt K; Schwarz TF
Vaccine; 2015 May; 33(22):2594-601. PubMed ID: 25882172
[TBL] [Abstract][Full Text] [Related]
10. Serological evaluation of poliomyelitis oral and inactivated vaccines in an urban low-income population at Rio de Janeiro, Brazil.
Schatzmayr HG; Maurice Y; Fujita M; de Fillipis AM
Vaccine; 1986 Jun; 4(2):111-3. PubMed ID: 3014770
[TBL] [Abstract][Full Text] [Related]
11. Lack of adjuvant effect of the pertussis component on IPV DTP-polio vaccine in children.
Cadoz M; Montagnon B; Yvonnet B; Xueref C; Vincent-Falquet JC; Bandet R; Gibelin N
Dev Biol Stand; 1986; 65():153-8. PubMed ID: 2881819
[TBL] [Abstract][Full Text] [Related]
12. [The immunological basis of the administration of DTP-polio vaccine].
Cohen H
Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
[TBL] [Abstract][Full Text] [Related]
13. [STATISTICO-CLINICAL DATA ON THE USE OF THE COMBINED DIPHTHERIA-PERTUSSIS-TETANUS-POLIOVIRUS VACCINE IN INFANTS].
GIURANNA U
Pediatria (Napoli); 1963; 71():962-7. PubMed ID: 14125501
[No Abstract] [Full Text] [Related]
14. Immunogenicity and safety of a tetravalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine.
Gyhrs A; Lyngholm E; Larsen SO; Aggerbeck H; Heron I
Scand J Infect Dis; 1999; 31(6):579-85. PubMed ID: 10680989
[TBL] [Abstract][Full Text] [Related]
15. Humoral immunity of dTap-IPV vaccine (REPEVAX®) administered one month after dT-IPV vaccine (REVAXIS®) in adults with unknown vaccination history.
Larnaudie S; Guiso N; Baptiste C; Desaint C; Desforges L; Lebon P; Soubeyrand B; Launay O
Hum Vaccin; 2010 Oct; 6(10):829-34. PubMed ID: 20864810
[TBL] [Abstract][Full Text] [Related]
16. A phase III, open-label, randomised multicentre study to evaluate the immunogenicity and safety of a booster dose of two different reduced antigen diphtheria-tetanus-acellular pertussis-polio vaccines, when co-administered with measles-mumps-rubella vaccine in 3 and 4-year-old healthy children in the UK.
Marlow R; Kuriyakose S; Mesaros N; Han HH; Tomlinson R; Faust SN; Snape MD; Pollard AJ; Finn A
Vaccine; 2018 Apr; 36(17):2300-2306. PubMed ID: 29576304
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.
Halperin SA; Tapiéro B; Dionne M; Meekison W; Diaz-Mitoma F; Zickler P; Rubin E; Embree J; Bhuyan P; Lee A; Li M; Tomovici A
Pediatr Infect Dis J; 2014 Jan; 33(1):73-80. PubMed ID: 24346596
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of a new, enhanced-potency, inactivated poliovirus vaccine.
Robertson SE; Traverso HP; Drucker JA; Rovira EZ; Fabre-Teste B; Sow A; N'Diaye M; Sy MT; Diouf F
Lancet; 1988 Apr; 1(8591):897-9. PubMed ID: 2895828
[TBL] [Abstract][Full Text] [Related]
19. Randomised feasibility trial of pre-exposure rabies vaccination with DTP-IPV in infants.
Lang J; Duong GH; Nguyen VG; Le TT; Nguyen CV; Kesmedjian V; Plotkin SA
Lancet; 1997 Jun; 349(9066):1663-5. PubMed ID: 9186385
[TBL] [Abstract][Full Text] [Related]
20. Present state and developments in the production of inactivated poliomyelitis vaccine.
van Wezel AL
Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]